Browse DORAS
Browse Theses
Search
Latest Additions
Creative Commons License
Except where otherwise noted, content on this site is licensed for use under a:

PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform

Claes, Jomme and Buys, Roselien and Woods, Catherine and Briggs, Andrew and Geue, Claudia and Aitken, Moira and Moyna, Niall and Moran, Kieran and McCaffrey, Noel and Walsh, Deirdre and Chouvarda, Ioanna and Budts, Werner and Filos, Dimitris and Triantafyllidis, Andreas and Maglaveras, Nicos and Cornelissen, Véronique (2017) PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform. BMJ Journals, 7 (6). pp. 1-12. ISSN 2044-6055

Full text available as:

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
713Kb

Abstract

Introduction. Exercise-based cardiac rehabilitation (CR) independently alters the clinical course of cardiovascular diseases resulting in a signi cant reduction in all-cause and cardiac mortality. However, only 15%–30% of all eligible patients participate in a phase 2 ambulatory programme. The uptake rate of community-based programmes following phase 2 CR and adherence to long-term exercise is extremely poor. Newer care models, involving telerehabilitation programmes that are delivered remotely, show considerable promise for increasing adherence. In this view, the PATHway (Physical Activity Towards Health) platform was developed and now needs to be evaluated in terms of its feasibility and clinical efficacy. Methods and analysis. In a multicentre randomised controlled pilot trial, 120 participants (m/f, age 40–80 years) completing a phase 2 ambulatory CR programme will be randomised on a 1:1 basis to PATHway or usual care. PATHway involves a comprehensive, internet- enabled, sensor-based home CR platform and provides individualised heart rate monitored exercise programmes (exerclasses and exergames) as the basis on which to provide a personalised lifestyle intervention programme. The control group will receive usual care. Study outcomes will be assessed at baseline, 3 months and 6 months after completion of phase 2 of the CR programme. The primary outcome is the change in active energy expenditure. Secondary outcomes include cardiopulmonary endurance capacity, muscle strength, body composition, cardiovascular risk factors, peripheral endothelial vascular function, patient satisfaction, health-related quality of life (HRQoL), well-being, mediators of behaviour change and safety. HRQoL and healthcare costs will be taken into account in cost-effectiveness evaluation. Ethics and dissemination. The study will be conducted in accordance with the Declaration of Helsinki. This protocol has been approved by the director and clinical director of the PATHway study and by the ethical committee of each participating site. Results will be disseminated via peer-reviewed scienti c journals and presentations at congresses and events.

Item Type:Article (Published)
Refereed:Yes
Uncontrolled Keywords:Exercise-based cardiac rehabilitation; Physical Activity Towards Health; telerehabilitation
Subjects:Medical Sciences > Health
DCU Faculties and Centres:DCU Faculties and Schools > Faculty of Science and Health > School of Health and Human Performance
Research Initiatives and Centres > INSIGHT Centre for Data Analytics
Publisher:BMJ Publishing Group
Official URL:http://dx.doi. org/10.1136/bmjopen-2017- 016781
Copyright Information:© 2017 The author(s) CC
Use License:This item is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 License. View License
Funders: EU’s Horizon 2020 Framework Programme for Research & Innovation Action under Grant no. 643491
ID Code:21924
Deposited On:16 Aug 2017 16:15 by Giulia Migliorato. Last Modified 15 Sep 2017 15:51

Download statistics

Archive Staff Only: edit this record